Overview

2018 was a strong year for our Tiara and Reducer product platforms. Both have achieved significant therapy development milestones, putting Neovasc on a stronger foundation from which to continue advancing these products commercially. We also have a clear value creation strategy for patients, employees, and investors. All of this is really good news for our outlook.

Read More >

Q1 2019 Earnings Webcast

Originally held Thursday, May 9, 2019

A replay of the event is available via webcast through August 9, 2019

 

Webcast >

Board Governance

 

Neovasc’s Board of Directors sets high standards for the company’s employees, officers and directors

 

MORE >

Presentations & Events

2019 AGM

June 4, 2019
8:00 a.m.

2600 – 595 Burrard Street
Vancouver, British Columbia

DETAILS >

News

 

The latest news releases from Neovasc

To automatically receive news updates

Register Now

CURRENT RELEASES + ARCHIVES >

Financial Reports

 

Fiscal 2018 End of Year Statements

Financial Statements

MD & A

Press Release

ARCHIVES >

Auditor

Grant Thornton LLP
Vancouver, BC

Legal Counsel

Blakes LLP
Vancouver, BC

Transfer Agent

Computershare
Vancouver, BC

Investor Relations

Chris Clark
Chief Financial Officer
investors@neovasc.com